Senate Bill 417
116th Congress(2019-2020)
Changing the Culture of the FDA Act
Introduced
Introduced in Senate on Feb 7, 2019
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
417
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No Senate votes have been held for this bill.
Summary
Changing the Culture of the FDA Act
This bill requires the Food and Drug Administration to amend its mission statement to take responsibility for protecting the public health by considering the danger of addiction and overdose death when approving and regulating prescription opioid medications. (Opioid medications are drugs with effects similar to opium, such as certain pain medications.)February 7, 2019
02/07/2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
02/07/2019
Introduced in Senate
Public Record
Record Updated
Nov 1, 2022 3:47:44 PM